Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;19(5):316-324.
doi: 10.1007/s11897-022-00563-0. Epub 2022 Aug 6.

Complications in Device Therapy: Spectrum, Prevalence, and Management

J Llewellyn  1 , D Garner  2   3 , A Rao  2
Affiliations
Review

Complications in Device Therapy: Spectrum, Prevalence, and Management

J Llewellyn et al. Curr Heart Fail Rep. 2022 Oct.

Abstract

Purpose of review: Cardiac implantable electronic device implant numbers are continually increasing due to the expanding indications and ageing population. This review explores the complications associated with device therapy and discusses ways to minimise and manage such complications.

Recent findings: Complications related to device therapy contribute to mortality and morbidity. Recent publications have detailed clear guidelines for appropriate cardiac device selection, as well as consensus documents discussing care quality and optimal implantation techniques. There have also been advances in device technologies that may offer alternative options to patients at high risk of/or already having encountered a complication. Adherence to guidelines, appropriate training, and selection of device, in addition to good surgical technique are key in reducing the burden of complications and improving acceptability of device therapy.

Keywords: Complications; Device therapy; Management.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance
    1. • Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427–520. This document details the most up-to-date evidence-based recommendations for cardiac pacing and cardiac resynchronisation. It was published alongside the updated heart failure guidelines bringing these closely related fields in line with each other. - PubMed - DOI
    1. Raatikainen MJP, Arnar DO, Merkely B, Nielsen JC, Hindricks G, Heidbuchel H, et al. A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2017 report from the European Heart Rhythm Association. Europace. 2017;19(suppl_2):ii1–90. - PubMed - DOI
    1. Programme NCA. National Audit of Cardiac Rhythm Management Report 2021. Accessed Online Feburary 2022. 2021.
    1. Chui PW, Wang Y, Ranasinghe I, Mitiku TY, Seto AH, Rosman L, et al. Association of physician specialty with long-term implantable cardioverter-defibrillator complication and reoperations rates. Circ Cardiovasc Qual Outcomes. 2019;12(6): e005374. - PubMed - PMC - DOI
    1. • Aktaa S, Abdin A, Arbelo E, Burri H, Vernooy K, Blomstrom-Lundqvist C, et al. European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology. Europace. 2022;24(1):165–72. This work relates to the development of quality indicators for care for patients undergoing device procedures in order to improve clinical outcomes. - PubMed - DOI

MeSH terms

LinkOut - more resources